Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Tissue Regenix Group Plc | LSE:TRX | London | Ordinary Share | GB00BNTXR104 | ORD 0.1P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| -0.50 | -0.85% | 58.50 | 1,711 | 09:55:13 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 58.00 | 59.00 | 59.00 | 58.50 | 59.00 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | USD 29.49M | USD -302k | USD -0.0043 | -136.05 | 41.64M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 09:55:14 | O | 3 | 58.65 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 21/11/2024 | 09:22 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 20/11/2024 | 14:07 | UK RNS | Tissue Regenix Group PLC Holding(s) in Company |
| 20/11/2024 | 11:16 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 20/11/2024 | 11:12 | UK RNS | Charles Stanley & Co. Ltd. Form 8.3 - Tissue Regenix Group plc |
| 19/11/2024 | 08:38 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 18/11/2024 | 12:43 | UK RNS | Harwood Capital Management Limited Form 8.3 - Tissue Regenix Group PLC |
| 15/11/2024 | 08:45 | UK RNS | IP Group PLC Form 8.3 - Tissue Regenix Group plc |
| 14/11/2024 | 09:19 | UK RNS | Cavendish Securities PLC Form 8.5 (EPT/NON-RI) |
| 13/11/2024 | 09:32 | UK RNS | Richard Griffiths Form 8.3 - Tissue Regenix Group Plc |
| 12/11/2024 | 16:05 | UK RNS | Tissue Regenix Group PLC Form 8 (OPD) (Tissue Regenix Group Plc) |
Tissue Regenix (TRX) Share Charts1 Year Tissue Regenix Chart |
|
1 Month Tissue Regenix Chart |
Intraday Tissue Regenix Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 21/11/2024 | 11:58 | Tissue Regenix delivering practical solutions to real clinical issues | 7,886 |
| 27/9/2021 | 17:42 | Tissue Regenix takes pole position in regeneration game | 2 |
| 26/5/2020 | 12:31 | Torex with Charts & News | 14 |
| 15/1/2020 | 07:09 | TOREX 2007 - THE TILLS RING AT LAST | 13 |
| 14/1/2020 | 20:51 | Terrane Minerals- Cu explorer, trading in Canada | 17 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 09:55:15 | 58.65 | 3 | 1.76 | O |
| 09:55:10 | 58.00 | 10 | 5.80 | O |
| 09:55:10 | 58.00 | 10 | 5.80 | O |
| 09:55:10 | 58.00 | 3 | 1.74 | O |
| 09:55:10 | 58.00 | 10 | 5.80 | O |
| Top Posts |
|---|
Posted at 21/11/2024 08:20 by Tissue Regenix Daily Update Tissue Regenix Group Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker TRX. The last closing price for Tissue Regenix was 59p.Tissue Regenix currently has 70,574,468 shares in issue. The market capitalisation of Tissue Regenix is £41,286,064. Tissue Regenix has a price to earnings ratio (PE ratio) of -136.05. This morning TRX shares opened at 59p |
Posted at 13/11/2024 11:33 by pj84 Edit Looking back through the recent holdings RNS's it looks like 3 of the major holders have been increasing their holdings, so that Lombard now has a holding of 12.57% and Richard Griffiths has a holding of 11.1% and Richard Snellor (with his wife and Inthallo) now have a holding of 15.23% which suggests something is happening as Richard Griffiths and Lombard often work together, particularly following the RNS issued by the company on 4 Nov saying:-"Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy." |
Posted at 06/11/2024 06:19 by onei So a quick check for comparable transactions suggests a multiple of 4 to 5 times sales.hxxps://www.healthca Copilot says that Stryker's acquisition of SERF SAS and Artelon were part of recent transactions reflecting these multiples, but I haven't actually found the figures to check this. Using the sales for the first half of 2024 and simply doubling that to get the annual sales and then using a multiple of 4 would equate to about 140p per share. |
Posted at 04/11/2024 17:27 by bamboo2 I could find no media speculation with a quick google search.It does look to me like an offer has been made. Maybe it's too low? ==================== Response to media speculation Tissue Regenix (AIM: TRX), notes the media speculation and confirms that it is conducting a review of the Company's strategic options that may include soliciting offers for the Company. As part of this, the Company has contacted a limited number of potential counterparties to assess whether such parties could put forward a proposal that would deliver greater value to Tissue Regenix's shareholders than pursuing a standalone independent strategy. The Company has not received any indicative non-binding proposals to date. There can be no certainty that any offer will be made as a result of contact with these potential counterparties, nor as to the terms on which any such offer might be made. Shareholders are advised to take no action at this time. A further announcement will be made in due course. Takeover Code notes The Takeover Panel Executive has granted a dispensation from the requirement of Rules 2.4 (a) and (b) of the Takeover Code such that Tissue Regenix is not required to identify in this announcement any potential offeror with which the Company is in talks, or from which an approach has been received, unless that potential offeror has been specifically identified in any rumour or speculation. As a consequence of this announcement, an 'offer period' has now commenced in respect of the Company in accordance with the Takeover Code, and the attention of shareholders is drawn to the disclosure requirements of Rule 8 of the Takeover Code, which are summarised below in "Disclosure Requirements of the Takeover Code". |
Posted at 25/9/2024 17:26 by cerrito With the concern that IHT tax treatment may be changed in the budget for AIM companies, does anyone know if TRX qualifies for IHT tax relief given that it's operations are in the US?? |
Posted at 12/9/2024 08:40 by tnt99 We made a profit at last should this continue and accelerate should see some positive share price reaction Must be at least double this price to bring me back to where I started in 2018 Doh!!! |
Posted at 10/9/2024 06:23 by p1nkfish Inflection likely when San Antonio on line.When bigger, another suitor could be Stryker but at current scale TRX won't float many boats. All reads well, needs scale. |
Posted at 06/9/2024 08:08 by contact2fsnetcouk Perhaps someone should send them an email with a link to the TRX website |
Posted at 13/7/2024 21:27 by pj84 simplicius I am not a chartist, but to chartists, the head and shoulders pattern signifies when a share has reached it's peak and the second shoulder confirms the start of a new downtrend (a bit like driving by looking in the rear view mirror to see what is coming next!) the inverse is just the opposite indicating the share has reached a bottom with the second shoulder confirming the start of a new uptrend.As with most things related to charts it often depends when you decide to choose the start of the trend and bamboo2 appears to be using the Feb high as the start of the inverse head and shoulders pattern but equally if you start it from a year or more ago you could say it is just continuing an uptrend with random movements in prices up and down in between. Fortunately in this case whilst not a chartist I also hope the share price trend will continue upwards. |
Posted at 03/7/2024 15:15 by bamboo2 IUG, also from the IPGroup stable, is in a very similar situation to TRX, as is also forecast to move to profit this year, but is not so fortunate in having share holders accumulating. It also derives much of its profit and growth from the US. |
Posted at 11/8/2022 10:11 by livewireplus :-)) unfortunately no refunds ... but had some good times ... have ended-up married - but as wife earns more than me then can't complain .... pass the Tissue from the left-hand side. An interesting week so far for the TRX share price .... |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
